Literature DB >> 8172943

Sleep in depression: the influence of age, gender and diagnostic subtype on baseline sleep and the cholinergic REM induction test with RS 86.

D Riemann1, F Hohagen, M Bahro, M Berger.   

Abstract

One hundred and eight healthy controls and 178 patients with a major depressive disorder according to DSM-III were investigated in the sleep laboratory after a 7-day drug wash-out period. Subsamples of 36 healthy controls and 56 patients additionally took part in the cholinergic rapid eye movement (REM) sleep induction test with RS 86. Data analysis revealed that age exerted powerful influences on sleep in control subjects and depressed patients. Sleep efficiency and amount of slow wave sleep (SWS) decreased with age, whereas the number of awakenings, early morning awakening, and amounts of wake time and stage 1 increased with age. REM latency was negatively correlated with age only in the group of patients with a major depression. Statistical analysis revealed group differences for almost all parameters of sleep continuity with disturbed indices in the depressed group. Differences in SWS were not detected. REM latency and REM density were altered in depression compared to healthy subjects. Sex differences existed for the amounts of stage 1 and SWS. The cholinergic REM induction test resulted in a significantly more pronounced induction of REM sleep in depressed patients compared with healthy controls, provoking sleep onset REM periods as well in those depressed patients showing baseline REM latencies in the normal range. Depressed patients with or without melancholia (according to DSM-III) did not differ from each other, either concerning baseline sleep or with respect to the results of the cholinergic REM induction test. The results stress the importance of age when comparing sleep patterns of healthy controls with those of depressed patients. Furthermore they underline the usefulness of the cholinergic REM induction test for differentiating depressed patients from healthy controls and support the reciprocal interaction model of nonREM-REM regulation and the cholinergic-aminergic imbalance hypothesis of affective disorders.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8172943     DOI: 10.1007/bf02191586

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  60 in total

1.  Induction and resetting of REM sleep rhythm in normal man by arecholine: blockade by scopolamine.

Authors:  N Sitaram; A M Moore; J C Gillin
Journal:  Sleep       Date:  1978-09       Impact factor: 5.849

2.  The utility of the REM latency test in psychiatric diagnosis: a study of 81 depressed outpatients.

Authors:  H S Akiskal; H Lemmi; B Yerevanian; D King; J Belluomini
Journal:  Psychiatry Res       Date:  1982-08       Impact factor: 3.222

Review 3.  Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia.

Authors:  R Tandon; J F Greden
Journal:  Arch Gen Psychiatry       Date:  1989-08

4.  Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep.

Authors:  D Riemann; H Gann; H Dressing; W E Müller; J B Aldenhoff
Journal:  Psychiatry Res       Date:  1994-03       Impact factor: 3.222

5.  The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.

Authors:  J M Palacios; G Bolliger; A Closse; A Enz; G Gmelin; J Malanowski
Journal:  Eur J Pharmacol       Date:  1986-06-05       Impact factor: 4.432

6.  Comparison of automated REM and slow-wave sleep analysis in young and middle-aged depressed subjects.

Authors:  D J Kupfer; C F Reynolds; R F Ulrich; V J Grochocinski
Journal:  Biol Psychiatry       Date:  1986-02       Impact factor: 13.382

7.  Electroencephalographic sleep in secondary depression: a revisit.

Authors:  M E Thase; D J Kupfer; D G Spiker
Journal:  Biol Psychiatry       Date:  1984-06       Impact factor: 13.382

8.  REM latency: a psychobiologic marker for primary depressive disease.

Authors:  D J Kupfer
Journal:  Biol Psychiatry       Date:  1976-04       Impact factor: 13.382

9.  Polysomnographic findings and dexamethasone nonsuppression in unipolar depression: a replication and extension.

Authors:  D E Giles; M A Schlesser; A J Rush; P J Orsulak; C L Fulton; H P Roffwarg
Journal:  Biol Psychiatry       Date:  1987-07       Impact factor: 13.382

10.  Neuroendocrinological and neurophysiological studies in major depressive disorders: are there biological markers for the endogenous subtype?

Authors:  M Berger; P Doerr; R Lund; T Bronisch; D von Zerssen
Journal:  Biol Psychiatry       Date:  1982-11       Impact factor: 13.382

View more
  16 in total

1.  Sleep Disturbances in Pediatric Depression.

Authors:  Uma Rao
Journal:  Asian J Psychiatr       Date:  2011-12

Review 2.  Sleep and mental disorders: A meta-analysis of polysomnographic research.

Authors:  Chiara Baglioni; Svetoslava Nanovska; Wolfram Regen; Kai Spiegelhalder; Bernd Feige; Christoph Nissen; Charles F Reynolds; Dieter Riemann
Journal:  Psychol Bull       Date:  2016-07-14       Impact factor: 17.737

3.  Scopolamine produces larger antidepressant and antianxiety effects in women than in men.

Authors:  Maura L Furey; Ashish Khanna; Elana M Hoffman; Wayne C Drevets
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

4.  Sleep EEG of patients with obsessive-compulsive disorder.

Authors:  F Hohagen; S Lis; S Krieger; G Winkelmann; D Riemann; R Fritsch-Montero; E Rey; J Aldenhoff; M Berger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

5.  Immunization of rats with conjugates of dopamine and serotonin with bovine serum albumin prevents the development of experimental MPTP-induced depressive syndrome (electrophysiological parameters).

Authors:  N B Pankova; L A Vetrilé; L A Basharova; N A Krupina; N N Khlebnikova; V I Rodina; G N Kryzhanovskii
Journal:  Neurosci Behav Physiol       Date:  2004-02

Review 6.  Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.

Authors:  Wayne C Drevets; Carlos A Zarate; Maura L Furey
Journal:  Biol Psychiatry       Date:  2012-11-28       Impact factor: 13.382

7.  The natural history of insomnia: acute insomnia and first-onset depression.

Authors:  Jason G Ellis; Michael L Perlis; Célyne H Bastien; Maria Gardani; Colin A Espie
Journal:  Sleep       Date:  2014-01-01       Impact factor: 5.849

8.  Randomised, double-blind study of the effects of oxybutynin, tolterodine, trospium chloride and placebo on sleep in healthy young volunteers.

Authors:  Konstanze Diefenbach; Frank Donath; Agathe Maurer; Sabine Quispe Bravo; Klaus-Dieter Wernecke; Ulrich Schwantes; Jutta Haselmann; Ivar Roots
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

9.  The effect of mood on sleep onset latency and REM sleep in interepisode bipolar disorder.

Authors:  Lisa S Talbot; Ilana S Hairston; Polina Eidelman; June Gruber; Allison G Harvey
Journal:  J Abnorm Psychol       Date:  2009-08

10.  Polysomnographic comparison between patients with primary alcohol dependency during subacute withdrawal and patients with a major depression.

Authors:  Horst Gann; Dietrich van Calker; Bernd Feige; Oliver Cloot; Rigo Brück; Mathias Berger; Dieter Riemann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-08       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.